Selection criteria for the Lung Cancer Vaccine

To opt for treatment with the therapeutic vaccines CIMAvax and Vaxira for lung cancer, patients must meet certain requirements which we list below:

1. The patient must be over 18 years old.
2. Patient with a diagnosis of Primary Lung Cancer defined as non-small cell cancer.
3. Cyto- and/or histological confirmation in stages IIIB or IV.
4. Patients who have completed the first line of oncospecific treatment (Chemo or Chemo/Radiotherapy, molecular target therapies).
5. That the objective response has been evaluated as stable disease, complete or partial remission, according to the established RECIST criteria, 4 weeks after completing the primary treatment and that no more than 8 weeks have elapsed weeks after completing this treatment.
6. Other studies of molecular targets and tumor markers that the patient has performed.
7. Result of imaging studies: CT, PET/CT at diagnosis. At the beginning and at the end of therapy.
8. That from the functional point of view does not have negative criteria: complementary within normal limits of Hematological and Hemochemical figures.
9. Life expectancy of at least 3 months.
10. WHO Clinical Status 0 to 2. (current clinical status of the patient).
11. That he is not a carrier of brain metastases.
12. Female patients of childbearing potential must use appropriate contraceptive methods and have a negative pregnancy test.
13. Patients who have signed the informed consent to receive this vaccine treatment.
14. The medical summary must be prepared by the attending physician of the country in question where it must be obtained. the express request for vaccination treatment must be recorded.
15. You must have a letter of authorization from the Regulatory Agency of the country of residence for the relevant customs procedures for the entry of the medication. (**)
16. You should not be receiving any other treatment.

The patient must meet all these criteria, which must be recorded in the documents evaluated by the Commission of Oncologists.

All information must be referred to by your treating oncologist.

(**) This section is strictly complied with, it must be previously discussed in your country and the immigration procedures must be resolved.

Related information

Vaccines for Lung Cancer

Price of the Lung Cancer Vaccine Treatment Program